Ironwood Pharmaceutical a News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.09.17	Location Intelligence Goes In-House with Ubimo's Polaris (PR Newswire)
07.09.17	New Drugs Approved In August (RTTNews)
22.08.17	FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed (RTTNews)
21.08.17	Generic Drugs Stock Performance Review -- Patheon, Zoetis, Ironwood Pharma, and Medicines Co. (PR Newswire)
21.07.17	Gainers & Losers Of July 20: SRPT, AKCA, AGRX, INO, IRWD... (RTTNews)
19.07.17	Technical Reports on Generic Drugs Equities -- Allergan, Ironwood Pharma, Medicines Co., and Catalent (PR Newswire)
12.06.17	Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma (PR Newswire)
01.05.17	How These Generic Drugs Stocks are Faring? -- Medicines Co., Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
28.03.17	Research Reports Initiation on Generic Drugs Stocks -- Medicines, Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
30.01.17	Generic Drugs Stocks on Investors' Radar -- Ironwood Pharma, Medicines, Rigel Pharma, and Lannett (PR Newswire)
30.01.17	Astellas And Ironwood Report Positive Results From Phase III Linaclotide Trial (RTTNews)
26.01.17	Ironwood, Allergan: FDA Approves 72mcg Dose Of Linzess For Adult CIC Patients (RTTNews)
05.01.17	AEZS Disappoints, EVOK Gets New Lease Of Life, GNMX Calls For Attention (RTTNews)
22.12.16	Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR-1 In IBS-C (RTTNews)
22.12.16	Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR2 (RTTNews)
20.12.16	How These Generic Drugs Stocks are Faring? -- Ironwood Pharma, Medicines, Lannett, and SCYNEXIS (PR Newswire)
03.06.16	AstraZeneca Completes US Licensing Deal With Ironwood Pharma For Lesinurad (RTTNews)
26.04.16	Ironwood To Acquire Exclusive US Rights To Gout Drug Zurampic From AstraZeneca (RTTNews)
06.04.16	The U.S. Gets 2nd Biosimilar, ORMP Awaits Data This Qtr, PFE Hits Mark In OPAL (RTTNews)
15.01.16	Obesity And Colorectal Cancer - Untangling The Link (RTTNews)
30.11.15	Ironwood Pharma Says Phase II Trial Of Linaclotide In OIC Meets Primary Endpoint (RTTNews)
27.10.15	Allergan Acquires Rights To CONSTELLA In More Than 40 Countries - Quick Facts (RTTNews)
14.10.15	ENZ Settles Suit With AFFX, PTLA On Fast Track, XTLB Given Enough Time (RTTNews)
08.07.15	AstraZeneca, Ironwood Report Positive Top-Line Data From Phase III IBS-C Trial (RTTNews)
13.02.15	ADHD Needs Your Attention, MOH In Good Health, GNCA Awaits Catalysts (RTTNews)
10.12.14	INFI Makes A Mark, IRWD For The Long Haul, MOVENTIG Approved In EU (RTTNews)
17.10.14	AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche (RTTNews)
08.01.14	Ironwood Pharmaceuticals To Reduce Headcount By About 10% - Quick Facts (RTTNews)
02.10.13	Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares (PR Newswire)
26.08.13	Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood (PR Newswire)
26.07.13	Earnings Releases, Investment Plans, Commencement of Clinical Trials, and FDA Applications Brighten Outlook - Research Report on Bard, Centene, Exact Sciences, Ironwood, and Merrimack (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	3’989.00	4.48 %	K V
Nestle	76.14	1.96 %	K V
Roche Hldg G	279.50	1.67 %	K V
Novartis	91.39	1.25 %	K V
Swisscom	512.00	1.19 %	K V
Sonova Hldg	316.70	-0.94 %	K V
Holcim	89.70	-1.67 %	K V
Logitech Intl	81.08	-1.75 %	K V
Part Grp Hldg	1’354.50	-2.52 %	K V
ABB	50.56	-6.37 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ironwood Pharmaceuticals Inc (A)

Aktien Top/Flop

Meistgelesene Nachrichten